AKBA

AKEBIA THREAPEUTICS INC

AKBA·00972D105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

AKBA (AKEBIA THREAPEUTICS INC) is held by 102 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($22.8M), VANGUARD CAPITAL MANAGEMENT LLC ($12.9M), AQR CAPITAL MANAGEMENT LLC ($10.4M). Net institutional sentiment: Mixed.

102
Holders
(10 Elite)
$111.4M
Total Value
64% (107)
Consensus
68 buying - 39 selling
13F: Insider & Congress: Updated regularly
AKBA

Smart Money Verdict

View all
Loading verdict
Held by 102 funds
10 elite

Who's Trading

Source dates: Price Oct 2, 2026 · Insiders Aug 10, 2026 · Activists May 12, 2026 · Congress none

InsiderBPButler John P.Exercise 350K shAug 6, 2026
InsiderOEOstrowski ErikSell $62KJun 29, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION4.3%May 12, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
20M(+6.9%)$22.8M0.0%-58.43%
31
Increased
11.3M(+1.4%)$12.9M0.0%-29.03%
28
Increased
9.2M(+410.5%)$10.4M0.0%-30.07%
45
Increased
6.7M(+4.3%)$7.7M0.0%-66.51%
29
Decreased
5.4M(-53.6%)$6.1M0.0%-57.50%
0
Increased
4.3M(+894.5%)$4.9M0.0%-26.17%
43
Increased
3.7M(+2.4%)$4.2M0.0%-54.17%
27
Increased
3.2M(+34.0%)$3.6M0.0%-55.76%
34
Increased
2.5M(+14.4%)$2.9M0.0%-28.51%
30
Increased
2.4M(+87.8%)$2.8M0.0%-27.70%
41
Increased
2.3M(+14.1%)$2.6M0.0%-59.42%
30
Increased
2.2M(+11.0%)$2.5M0.0%-65.87%
29
Increased
1.9M(+7.3%)$2.2M0.0%-28.78%
28
Increased
1.9M(+40.1%)$2.1M0.0%-45.77%
34
Decreased
1.8M(-25.7%)$2M0.0%-66.45%
0
Increased
1.7M(+23.6%)$2M0.0%-51.74%
31
Increased
1.4M(+78.7%)$1.6M0.0%-55.34%
39
Decreased
1.2M(-33.2%)$1.4M0.0%-31.51%
0
Decreased
1.1M(-60.6%)$1.3M0.0%-61.52%
0
Increased
701,540(+20.7%)$799,7560.0%-63.26%
20

Showing 1-20 of 115

1 / 6
AKBAAKBAAKEBIA THREAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used